3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Lymphoma, Large B-Cell, Diffuse
5
Prostatic Neoplasms
3
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Lymphoma
2
Triple Negative Breast Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Immunoblastic Lymphadenopathy
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Adenocarcinoma
1
Interventions
Peripheral Blood Stem Cell Transplantation
5
Cyclophosphamide
5
romidepsin
4
pembrolizumab
4
Lenalidomide
4
Etoposide
4
10-propargyl-10-deazaaminopterin
4
Rituximab
3
fludarabine phosphate
2
fludarabine
2
durvalumab
2
carmustine, poliferprosan 20 drug combination
2
Vincristine
2
Prednisone
2
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
Melphalan
2
Gemcitabine
2
Doxorubicin
2
Depsipeptides
2
Cytarabine
2
Carmustine
2
Bendamustine Hydrochloride
2
AFM13
2
veliparib
1
thymoglobulin
1
tenalisib
1
temsirolimus
1
prednylidene
1
mogamulizumab
1
forodesine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Lymphoma, T-Cell
×
Prednisolone
×
Clear all
NCT01198665
2015-03-03
RADCHOP
Samsung Medical Center
Phase 1/2
Completed
46 enrolled